Extraction of high-integrity RNA suitable for microarray gene expression analysis from long-term stored human thyroid tissues.
Author(s): Walter MA, Seboek D, Demougin P, Bubendorf L, Oberholzer M, Müller-Brand J, Müller B
Publication: Pathology, 2006, Vol. 38, Page 249-53
PubMed ID: 16753748 PubMed Review Paper? No
Purpose of Paper
The purpose of this paper was to determine if RNA integrity and expression in malignant and non-malignant thyroid tissue are adversely affected by prolonged storage (1-16 y) of snap-frozen specimens at -70°C.
Conclusion of Paper
Although RNA yields from malignant and nonmalignant thyroid tissue specimens did not differ significantly, slightly higher median RNA yields were observed from malignant tissue (2.1-2.4 µg/mg) than non-malignant tissue (1.4-1.6 µg/mg). Multiple regression analysis revealed that RNA integrity numbers (RIN) was not correlated to tissue storage duration and did not differ significantly between RNA extracted from malignant and non-malignant thyroid tissue. The percentage of genes represented on the Human U333 Plus 2.0 array that were expressed in goiter (51.5%), follicular adenoma (48.1%), papillary carcinoma (52.0%), and follicular carcinoma (42.7%) specimens were within the expected range (30-55%). The 3’/5’ ratio of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcripts was also well below the threshold for degradation (3.0) for all sample types: goiter (1.43), follicular adenoma (1.34), papillary carcinoma (1.52), and follicular carcinoma (1.29). Collectively, the results led the authors to conclude that RNA isolated from snap-frozen malignant and non-malignant thyroid tissue stored at -70°C for up to 11 y is suitable for gene expression profiling using microarray.
Studies
-
Study Purpose
The purpose of this study was to determine if RNA integrity and expression in malignant and non-malignant thyroid tissue are adversely affected by prolonged storage (1-16 y) of snap-frozen specimens at -70°C. In total, 79 surgically resected thyroid specimens that included malignant (30 papillary carcinomas, 14 follicular carcinomas) and non-malignant (15 goiters, 20 follicular adenomas) tissue were used for analysis. Within 15-30 min of surgical resection, specimens were embedded in OCT compound, snap-frozen in isopentane pre-cooled with liquid nitrogen, and stored at -70°C for 1-16 y until analysis. RNA was isolated from 10 mg of tissue by Trizol/chloroform extraction, purified with RNeasy mini-spin columns, and treated with DNAse. RNA integrity number (RIN) was determined with a Bioanlyzer 2100. Gene expression profiling and the 3’/5’ ratio of GAPDH transcripts were assessed using 5 µg of total RNA and a Human U133 Plus 2.0 Genechip.
Summary of Findings:
RNA yields from malignant and nonmalignant thyroid tissue specimens did not differ significantly, although higher median RNA yields were observed from malignant tissue (2.1-2.4 µg/mg) than non-malignant tissue (1.4-1.6 µg/mg). Multiple regression analysis revealed that RIN was not correlated to tissue storage duration (r2=0.012, p=0.34). RIN also did not differ significantly between RNA extracted from malignant and non-malignant thyroid tissue (p=0.10). The percentage of genes represented on the Human U333 Plus 2.0 array that were expressed in goiter (51.5%), follicular adenoma (48.1%), papillary carcinoma (52.0%), and follicular carcinoma (42.7%) specimens were within the expected range (30-55%). The 3’/5’ ratio of GAPDH transcripts was also well below the threshold for degradation (3.0) for all sample types: goiter (1.43), follicular adenoma (1.34), papillary carcinoma (1.52), and follicular carcinoma (1.29). Collectively, the results led the authors to conclude that RNA isolated from snap-frozen malignant and non-malignant thyroid tissue that has been stored at -70°C for up to 11 y is of suitable quality for gene expression profiling using microarray.
Biospecimens
Preservative Types
- OCT
- Frozen
Diagnoses:
- Neoplastic - Benign
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform RNA DNA microarray RNA Automated electrophoresis/Bioanalyzer Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Malignant
Non-malignant
Storage Storage duration 1-16 y
DNA microarray Specific Targeted nucleic acid GAPDH